Stock Market Reviews

Read and share opinions on MYNZ (Mainz Biomed N.V.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
  Nov 12, 2025
• Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
  Nov 10, 2025
• Mainz Biomed to Attend 2025 Maxim Growth Summit
  Oct 15, 2025
• Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
  Oct 8, 2025
• Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
  Sep 30, 2025
• Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
  Sep 23, 2025
• Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
  Sep 2, 2025
• Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
  Aug 13, 2025
• Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
  Aug 4, 2025
• Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
  Jul 23, 2025
• Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
  Jul 15, 2025
• Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
  Jun 25, 2025
• Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
  Jun 10, 2025
• Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
  May 20, 2025
• Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
  May 16, 2025
• Mainz Biomed Enters into Technology Partnership with EDX Medical Group
  Apr 29, 2025
• Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
  Apr 28, 2025
• Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
  Apr 1, 2025